000423 Stock Overview
Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Dong-E-E-Jiao Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥62.36 |
| 52 Week High | CN¥72.91 |
| 52 Week Low | CN¥44.62 |
| Beta | 0.70 |
| 1 Month Change | 9.06% |
| 3 Month Change | 5.50% |
| 1 Year Change | 28.31% |
| 3 Year Change | 36.28% |
| 5 Year Change | 75.46% |
| Change since IPO | 3,796.99% |
Recent News & Updates
We Think Dong-E-E-JiaoLtd's (SZSE:000423) Robust Earnings Are Conservative
Nov 06
Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) Shares Climb 34% But Its Business Is Yet to Catch Up
Oct 14Recent updates
We Think Dong-E-E-JiaoLtd's (SZSE:000423) Robust Earnings Are Conservative
Nov 06Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) Shares Climb 34% But Its Business Is Yet to Catch Up
Oct 14Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Shares Could Be 37% Below Their Intrinsic Value Estimate
Sep 13Are Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Investors Paying Above The Intrinsic Value?
May 21Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest
Mar 31Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results
Mar 25Some Shareholders Feeling Restless Over Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) P/E Ratio
Mar 21Shareholder Returns
| 000423 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 4.2% | -1.7% | -1.0% |
| 1Y | 28.3% | -4.3% | 10.8% |
Return vs Industry: 000423 exceeded the CN Pharmaceuticals industry which returned -4.3% over the past year.
Return vs Market: 000423 exceeded the CN Market which returned 10.8% over the past year.
Price Volatility
| 000423 volatility | |
|---|---|
| 000423 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 000423 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000423's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | 3,678 | Jie Cheng | www.dongeejiao.com |
Dong-E-E-Jiao Co.,Ltd. research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods. The company was founded in 1952 and is based in Liaocheng, China.
Dong-E-E-Jiao Co.,Ltd. Fundamentals Summary
| 000423 fundamental statistics | |
|---|---|
| Market cap | CN¥40.62b |
| Earnings (TTM) | CN¥1.52b |
| Revenue (TTM) | CN¥5.62b |
26.4x
P/E Ratio7.1x
P/S RatioIs 000423 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000423 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.62b |
| Cost of Revenue | CN¥1.52b |
| Gross Profit | CN¥4.10b |
| Other Expenses | CN¥2.58b |
| Earnings | CN¥1.52b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.36 |
| Gross Margin | 72.92% |
| Net Profit Margin | 27.05% |
| Debt/Equity Ratio | 0% |
How did 000423 perform over the long term?
See historical performance and comparisonDividends
3.7%
Current Dividend Yield124%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 12:56 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dong-E-E-Jiao Co.,Ltd. is covered by 36 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anthony Lok | BOCI Research Ltd. |
| Bo Li | BOCOM International Securities Limited |
| Jessica Li | BofA Global Research |